Daily Financial Update
Good Saturday morning. I’m not here to coddle you with fluff—here’s a straight-up recap of what moved markets yesterday and what to watch when Monday’s bell rings.
Opening Recap
Market Pulse: Bitcoin regained ground as Binance flows balanced the CVD metric, fueling a bullish shift in crypto. Levi Strauss shares slipped despite an earnings beat, and Teva’s FDA win nudged pharma into focus.
Key Movers: Bitcoin buyers on Binance (newsBTC), Levi Strauss dives after its earnings beat (Biztoc), and Teva’s expanded Uzedy label (Thefly) steered sentiment. Bluejay Diagnostics also drew eyes with its $4.5 M at-the-market raise.
Macro & Politics: Rumors of a Fed rate cut are tightening their grip on markets, while Chinese regulators’ crackdown on memecoins reminded everyone that state power still rules crypto.
What’s Next: Watch for Monday’s Fed speakers and retail sales data—those will decide if bulls keep charging or bears claw back.
Market Commentary
Everyone’s missing that a beaten-up Levi Strauss is signaling a deeper consumer freeze despite beating on earnings—a classic trap where “beats” mean squat if top-line growth is flat. Meanwhile, China’s memecoin purge shows how fast regulators can yank the rug under inflated crypto positions, damn.
Consider how Teva’s Uzedy approval and Bluejay’s quiet $4.5 M raise form a blueprint: lock in regulatory clarity, then stockpile cash before your catalysts arrive. Markets will reward runway over hype, so don’t get caught in bullshit.
Stop chasing yesterday’s narratives. If you’re long risk, target crypto short-squeeze setups but hedge with Teva’s new label and biotech names that actually deliver. Otherwise you’re gambling, not investing.
📈 Breaking Financial News
Teva announces FDA approval of Uzedy for bipolar I disorder
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Bitcoin – Why BTC’s next move could hinge on THIS price zone
Bitcoin’s renewed investor confidence signals recovery, but resistance at $123K may challenge bullish momentum.
Bitcoin Traders Tilt Bullish as Short Squeeze Looms While Chinese Memecoins Crash
Bitcoin’s rebound from overnight lows has reignited bullish sentiment across crypto markets, with institutional inflows and leveraged positioning pointing to potential upside.
Bitcoin Buyers Dominate On Binance As CVD Confirmation Nears 0.9, Signaling $130K Target Zone
Following a new all-time high (ATH) of $126,199 on Binance, Bitcoin (BTC) is now consolidating in the low $120,000 range. Latest exchange data – such as Cumulative Volume Delta (CVD) Confirmation Score – suggests that BTC is benefitting from strong underlying…
The Real Reason 218,000 Acres Just Vanished
The government just quietly leased 218,000 acres in the middle of Utah's Black Desert. Why? Not for oil or solar—this is a new kind of energy story backed by Buffett, Gates, Bezos, and Zuckerberg.
🔍 Market Analysis & Insights
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced the closing of its previously announced p…
Price predictions 10/10: BTC, ETH, BNB, XRP, SOL, DOGE, ADA, HYPE, LINK, SUI
Bitcoin has fallen below $116,000, but select analysts remain unfazed as they anticipate solid buying to emerge at lower levels.
FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Oct. 10, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Dru…
Press release: Transparency Notification from Shareholder
Transparency Notification from Shareholder Ghent, Belgium – 10 October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana…).
Molecule Therapeutics Market Size, Companies and Emerging Technologies Insight – Towards Healthcare
This comprehensive report by Towards Healthcare, a sister firm of Precedence Research, provides in-depth insights into the global molecule therapeutics market, covering market size, emerging trends, key players, and strategic developments shaping the industry…
You WILL buy these four miners [now or when the herd panics]
BREAKING: The Senate just passed Trump’s “Big Beautiful Bill,” adding $10 trillion to the debt. That means big gains for gold miners. Learn about four “Golden Anomaly” miners selling at discounts up to 90% below the in-ground value.
💰 Investment Opportunities
Medical Animation Global Forecast Report 2025-2032: Market to Grow at a CAGR of 23.82%
Medical animation transforms healthcare learning, offering opportunities in education, training, and patient engagement. Key growth areas include immersive technologies (AR/VR), AI-driven production, regional expansions, and strategic partnerships, despite fa…
Bitcoin Ready for ‘Big Moves' on 91% Chance of Fed Rate Cut: Crypto Daybook Americas
The day ahead in crypto: Oct. 10, 2025
Bitcoin’s 55% short skew sparks debate: Hedge or hype?
Shorts stack, liquidity piles – BTC’s weekly drama unfolds.
ProstaVive Highlights Research-Backed Prostate Health Support Formula Focused on Blood Flow and Nitric Oxide Optimization
Manufacturer Reports Rising Global Interest in Nitric Oxide–Supporting Formula as Men Seek Natural, Research-Based Solutions for Prostate Wellness and Circulatory Health Manufacturer Reports Rising Global Interest in Nitric Oxide–Supporting Formula as Men See…
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agree…
Is the White House Sabotaging the Dollar?
Experts warn that the “Mar-a-Lago Accord” could send the dollar into a tailspin. Millionaire trader Tim Sykes reveals a weekend loophole to protect your wealth and even profit while markets are closed.
